Ferritinophagy and ferroptosis in the management of metabolic diseases

No Thumbnail Available
File version
Author(s)
Ajoolabady, A
Aslkhodapasandhokmabad, H
Libby, P
Tuomilehto, J
Lip, GYH
Penninger, JM
Richardson, DR
Tang, D
Zhou, H
Wang, S
Klionsky, DJ
Kroemer, G
Ren, J
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
License
Abstract

Ferroptosis is a form of regulated cell death modality associated with disturbed iron-homeostasis and unrestricted lipid peroxidation. Ample evidence has depicted an essential role for ferroptosis as either the cause or consequence for human diseases, denoting the likely therapeutic promises for targeting ferroptosis in the preservation of human health. Ferritinophagy, a selective form of autophagy, contributes to the initiation of ferroptosis through degradation of ferritin, which triggers labile iron overload (IO), lipid peroxidation, membrane damage, and cell death. In this review, we will delineate the role of ferritinophagy in ferroptosis, and its underlying regulatory mechanisms, to unveil the therapeutic value of ferritinophagy as a target in the combat of ferroptosis to manage metabolic diseases.

Journal Title

Trends in Endocrinology and Metabolism

Conference Title
Book Title
Edition
Volume

32

Issue

7

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Paediatrics

Reproductive medicine

Clinical sciences

ferritinophagy

ferroptosis

iron overload

lipid peroxidation

metabolic diseases

Persistent link to this record
Citation

Ajoolabady, A; Aslkhodapasandhokmabad, H; Libby, P; Tuomilehto, J; Lip, GYH; Penninger, JM; Richardson, DR; Tang, D; Zhou, H; Wang, S; Klionsky, DJ; Kroemer, G; Ren, J, Ferritinophagy and ferroptosis in the management of metabolic diseases, Trends in Endocrinology and Metabolism, 2021, 32 (7), pp. 444-462

Collections